Corporate Governance
Good corporate governance - pointing out corporate directors who should and shouldn't be elected anywhere. This is my attempt to keep track of good people for board of directors and keep track of people who should be avoided.Tuesday, September 12, 2006
Okay corporate governance at Bristol-Myers Squibb
People were calling for the ouster of former CEO Peter Dolan for simply doing a bad job. The board was basically forced into it because the CEO may have broken the law.
It's a shame they waited this long to do this - bad performance is enough to oust a CEO, it shouldn't have come to this.
In any case, here's the names of the people on the board of BMY. I'm not sure whether or not they should be congratulated for their good decision or avoided for waiting so long.
James D. Robinson III
Non-Executive Chairman, Bristol-Myers Squibb and Chairman
and Chief Executive Officer, RRE Investors
Former CEO of American Express, member of the board of directors of Coca Cola, First Data Corp, and Novell.
Robert E. Allen
Retired Chairman and Chief Executive Officer, AT&T Corporation
Lewis B. Campbell
Chairman, President and Chief Executive Officer, Textron Inc.
Member of the Board of Directors of Dow Jones.
Vance D. Coffman
Former Chairman and Chief Executive Officer, Lockheed Martin Corporation
Member of the Board of Directors of 3M. Member of the Board of Directors at Deere & Company.
James M. Cornelius
Interim Chief Executive Officer, Bristol-Myers Squibb and Guidant Board Chairman Emeritus
Former CFO of Eli Lilly. Co-Founder of Guidant. Also a Director of The Chubb Corporation, The DirecTV Group, Inc. and Given Imaging, Ltd.
Louis J. Freeh
Former Vice Chairman, MBNA America Bank, N.A. Former director of the FBI.
Laurie H. Glimcher, M.D.
Irene Heinz Given Professor of Immunology, Harvard School of Public Health and Professor of Medicine, Harvard Medical School
Leif Johansson
President, AB Volvo and Chief Executive Officer, The Volvo Group
Vicki L. Sato, Ph.D.
Professor of Management Practice, Harvard Business School, and Professor of Molecular and Cell Biology, Harvard University.
Retired President of Vertex Pharmaceuticals. Member of the Board of Directors of PerkinElmer Corporation, Infinity Pharmaceuticals and Alnylam Pharmaceuticals.
R. Sanders Williams, M.D.
Dean of Duke University School of Medicine and the Vice Chancellor for Academic Affairs at Duke University Medical Center
Most of the information in the bios of the above people were NOT found on the BMY board of directors web page but instead through google searches.
That's reassuring.
It's a shame they waited this long to do this - bad performance is enough to oust a CEO, it shouldn't have come to this.
In any case, here's the names of the people on the board of BMY. I'm not sure whether or not they should be congratulated for their good decision or avoided for waiting so long.
James D. Robinson III
Non-Executive Chairman, Bristol-Myers Squibb and Chairman
and Chief Executive Officer, RRE Investors
Former CEO of American Express, member of the board of directors of Coca Cola, First Data Corp, and Novell.
Robert E. Allen
Retired Chairman and Chief Executive Officer, AT&T Corporation
Lewis B. Campbell
Chairman, President and Chief Executive Officer, Textron Inc.
Member of the Board of Directors of Dow Jones.
Vance D. Coffman
Former Chairman and Chief Executive Officer, Lockheed Martin Corporation
Member of the Board of Directors of 3M. Member of the Board of Directors at Deere & Company.
James M. Cornelius
Interim Chief Executive Officer, Bristol-Myers Squibb and Guidant Board Chairman Emeritus
Former CFO of Eli Lilly. Co-Founder of Guidant. Also a Director of The Chubb Corporation, The DirecTV Group, Inc. and Given Imaging, Ltd.
Louis J. Freeh
Former Vice Chairman, MBNA America Bank, N.A. Former director of the FBI.
Laurie H. Glimcher, M.D.
Irene Heinz Given Professor of Immunology, Harvard School of Public Health and Professor of Medicine, Harvard Medical School
Leif Johansson
President, AB Volvo and Chief Executive Officer, The Volvo Group
Vicki L. Sato, Ph.D.
Professor of Management Practice, Harvard Business School, and Professor of Molecular and Cell Biology, Harvard University.
Retired President of Vertex Pharmaceuticals. Member of the Board of Directors of PerkinElmer Corporation, Infinity Pharmaceuticals and Alnylam Pharmaceuticals.
R. Sanders Williams, M.D.
Dean of Duke University School of Medicine and the Vice Chancellor for Academic Affairs at Duke University Medical Center
Most of the information in the bios of the above people were NOT found on the BMY board of directors web page but instead through google searches.
That's reassuring.
posted by Larry Diamond # 9:07 PM 
Subscribe to
Posts [Atom]
View mobile version
Archives
August 2006 September 2006 October 2006 November 2006 January 2007 April 2007 May 2007 August 2007 September 2007 October 2007 December 2007 February 2008 March 2008 April 2008 June 2008 July 2008 August 2008 November 2008 February 2009 May 2009 June 2009 July 2009 August 2009
